PTN
Palatin Technologies Inc
AMEX: PTN · HEALTHCARE · BIOTECHNOLOGY
$20.21
-0.30% today
Updated 2026-04-30
Market cap
$37.58M
P/E ratio
—
P/S ratio
4.19x
EPS (TTM)
$-8.26
Dividend yield
—
52W range
$2 – $31
Volume
0.0M
Palatin Technologies Inc (PTN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$20.21
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$21.70
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $-0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -107.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.